Pharmaceuticals

Ophthalmic Drugs Market Future Outlook Showing Growth Toward $29.13 Billion By 2030

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Ophthalmic Drugs Market Expected To Change From 2026 To 2030?

The ophthalmic drugs market has witnessed strong growth in recent years. Forecasts indicate it will expand from $42.25 billion in 2025 to $45.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. This historic growth is attributable to an increasing aging population, a rising incidence of glaucoma and cataract, the proliferation of ophthalmology clinics, improved access to prescription eye medicines, and the expansion of hospital pharmacy networks.

The ophthalmic drugs market is projected to experience robust expansion in the coming years, anticipated to reach $61.21 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. Key factors contributing to this growth during the forecast period include progress in sustained-release ocular drug delivery systems, a greater public understanding of eye health, an increase in treatments for retinal disorders, escalating healthcare spending in developing nations, and the broader acceptance of over-the-counter (OTC) ophthalmic products. Significant trends identified for this period encompass the increasing occurrence of chronic eye conditions, a heightened need for dry eye treatments, the wider use of combination ophthalmic medications, a move towards formulations without preservatives, and the proliferation of online pharmacies offering eye drugs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10065&type=smp

Which Key Factors Are Driving The Ophthalmic Drugs Market Growth?

The ophthalmic drug market is projected to grow as the prevalence of ophthalmic disorders increases. Ophthalmic disorders are conditions or diseases affecting the eye and its parts, resulting in vision impairment and other eye ailments. Ophthalmic drugs are pharmaceutical medicines utilized for treating diseases impacting the eye or vision, and consequently, the rising occurrence of ophthalmic disorders boosts the demand for the ophthalmic drug market. For instance, in August 2023, data from the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, indicated that at least 2.2 billion people worldwide were living with near or distance vision impairment in 2023. Over 1 billion of these cases were preventable or untreated, with refractive errors and cataracts being the primary causes, while intervention reach was limited to just 36% and 17%, respectively. This increase in the prevalence of ophthalmic disorders is a key driver for the ophthalmic drug market.

How Are Segments Identified Within The Ophthalmic Drugs Market Segment Framework?

The ophthalmic drugs market covered in this report is segmented –

1) By Type: Prescription Drugs, Over-The-Counter Drugs

2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes

3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases

4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems

5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Prescription Drugs: Antiglaucoma Agents, Anti-inflammatory Drugs, Antibiotics, Antivirals, Corticosteroids, Other Prescription Drugs

2) By Over-The-Counter Drugs: Artificial Tears, Allergy Relief Medications, Redness Relievers, Ocular Vitamins And Supplements, Other OTC Drugs

Which Trends Are Contributing To Changes In The Ophthalmic Drugs Market?

Leading companies in the ophthalmic drugs market are concentrating on developing preservative-free medications, including preservative-free latanoprost, to offer an efficient treatment choice. Preservative-free latanoprost refers to a specific preparation of the drug latanoprost, employed in treating ailments such as glaucoma. For instance, in September 2023, Thea Pharma, a US-based pharmaceutical company specializing in the commercialization of eye care products, launched Iyuzeh (latanoprost ophthalmic solution) 0.005%, which is the first preservative-free latanoprost for primary open-angle glaucoma (POAG) and ocular hypertension (OHT) in the US. Iyuzeh, having received FDA approval in December 2022, presents an effective therapeutic alternative for over 60 million individuals globally affected by glaucoma.

Who Are The Companies Competing Within The Ophthalmic Drugs Market?

Major companies operating in the ophthalmic drugs market are AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Laboratoires Théa

Get The Full Ophthalmic Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

Which Region Leads The Ophthalmic Drugs Market In Terms Of Market Share?

North America was the largest region in the ophthalmic drugs market in 2025. The regions covered in the ophthalmic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Ophthalmic Drugs Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

Browse Through More Reports Similar to the Global Ophthalmic Drugs Market 2026, By The Business Research Company

Ophthalmic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

Ophthalmology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Anemia And Other Blood Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795